Ignite Creation Date:
2024-05-05 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 9:46 AM
Study NCT ID:
NCT00637390
Status:
TERMINATED
Last Update Posted:
2016-12-02
First Post:
2008-03-10
Brief Title:
A Phase I Study of Alemtuzumab in Patients With Relapsed OvarianPrimary Peritoneal Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Peritoneal Cancer |
| Ovarian Cancer |
| Fallopian Tube Cancer |
Keywords: